Showing results (2041-2050 of 2,289) with videos related to

Sort By:
Pageof 229
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2024
Dry-Cleaning Chemicals and a Cluster of Parkinson's Disease and Cancer: A Retrospective InvestigationE Ray Dorsey, Dan Kinel, Meghan E Pawlik, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2017
Atomic structure of a toxic, oligomeric segment of SOD1 linked to amyotrophic lateral sclerosis (ALS)Smriti Sangwan, Anni Zhao, Katrina L Adams, et al.
Journal of Parkinson'S Disease|May 22, 2023
Relative Meaningfulness and Impacts of Symptoms in People with Early-Stage Parkinson's DiseaseJennifer R Mammen, Rebecca M Speck, Glenn T Stebbins, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Discovery of Chromane Propionic Acid Analogues as Selective Agonists of GPR120 with in Vivo Activity in RodentsGregory L Adams, Francisco Velazquez, Charles Jayne, et al.
Plos Medicine|September 16, 2008
Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studiesMichael J Thun, Lindsay M Hannan, Lucile L Adams-Campbell, et al.
Molecular Genetics and Metabolism|September 27, 2014
Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosisBrian R Vuillemenot, Derek Kennedy, Jonathan D Cooper, et al.
Journal of Pharmaceutical Sciences|October 28, 2017
An Intercompany Perspective on Biopharmaceutical Drug Product Robustness StudiesSorina Morar-Mitrica, Monica L Adams, George Crotts, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemiaF C Barone, E A Irving, A M Ray, et al.
NAR Cancer|February 4, 2025
Histone H3E50K remodels chromatin to confer oncogenic activity and support an EMT phenotypeKirti Sad, Dorelle V Fawwal, Celina Y Jones, et al.
Pageof 229